Bernstein analyst William Pickering maintained a Buy rating on Biohaven Ltd. (BHVN – Research Report) today and set a price target of $63.00.

Antidepressants are among the most commonly prescribed medications in the United States. In 2017 to 2018, 14% of U.S. adults ...

Heat can act as both a notorious trigger or a soothing remedy for migraines. We dug into the intricate balance pain sufferers ...

Duke neuroscientist Kafui Dzirasa wants nothing less than to reengineer the brain’s electrical patterns to treat anxiety, ...

Dogs really are our best friends - and they could also be the key to our health, as they can pick up on a huge number of ...

We recently compiled a list of the 12 Most Reliable Dividend Stocks To Buy According to Hedge Funds. In this article, we are ...

Headaches on the right side can stem from tension, migraines, cluster headaches, or sinus infections. Read on to know more.

Scene… Mr. Falafel Mediterranean Cuisine & Gelato has opened at 1239 East Putnam Ave. The new hot spot serves authentic ...

Until now, the best option for doctors to treat a stroke patient's blood clot at Ascension Scared Heart was a drug. But there ...

Ashwani Kumar Chrungoo On 6th January 2025, the highly controversial Prime Minister of Canada, Justin Trudeau announced his ...